Who We Are
Sergey Selifonov Bio >
[http://www.linkedin.com/in/selifonov]
Olga Selifonova Bio >
[http://www.linkedin.com/in/selifonova]

Sergey and Olga are seasoned entrepreneurs on a mission to make this world a better place. Using an evolutionary approach to guide R&D efforts, we discover patterns and concepts that enable technological breakthroughs not seen by others.

Periods of stealth operations, enabled by ownership of R&D assets for experimental studies and key relationships with leading specialist organizations, allow us to contemplate and maintain a portfolio of one-of-the-kind transformative technologies in the fields of sustainability, renewable industrial products, functional nutrition and biotechnology. As architects of change, we build our technology on clean IP position and FTO strategy in a decision process unobstructed by institutional bureacracies.

We thoroughly evaluate technology risks, implementation team risks and other potential "show stoppers" before endorsing major commitments of working capital for pursuit of untested technologies that have seemingly attractive business models. We offer honest fact- and data-supported opinions for the sell side and for the buy side in the due diligence process of potential technology transactions and technology investments.

During last decade we have started several companies and ventures based on Sergey's inventions. Among them are Аromagen Corporation (2002), Segetis, Inc. (2006), Reluceo, Inc. (2009), XLTerra, Inc. (2009) and Reluceo Holdings LLC (late 2013). Аromagen and Reluceo Holdings LLC have been funded by the founders. Segetis, Reluceo and XLTerra have received Series A financing from Khosla Ventures.

We have relocated to the San Francisco Bay Area in late 2015 after two years of stealth development and consolidation of certain technology assets. Reluceo Holdings (now part of Selifonov Technology Enterprises) is focusing on depoyment of the Grasplex project.

As your destination for expert advice, we welcome your inquiries regarding collaboration opportunities in company creation and building, and regarding technology offerings for venture capital firms and corporations.


Sergey Selifonov is President, Chief Technology Officer, and Founder of Reluceo Holdings LLC since 2013. Prior to current position, Sergey served as President and CTO of Reluceo Inc, and XLTerra, Inc. (2009-2013), Minnesota-based VC-backed green chemistry companies dedicated to development of renewable and degradable polymers such as non-acrylic superabsorbents (hydrogels) and high performance plastics from non-food biomass sources. Sergey also founded Segetis, Inc. (2006) and Аromagen Corporation (2002). Аromagen, a chemical biotechnology company, was capitalizing on synergies between biocatalysis and chemistry for discovery and production of value added chemical products (flavors, fragrances, industrial materials). As Аromagen's President and Chief Scientific Officer, Sergey led development of select products in industrial partnerships with Archer Daniels Midland Company in industrial chemicals, and with a "Big Five" F&F company in bioprocess development. Sergey's work at Аromagen has included the key steps of discovery and enablement of levulinic ketal ("L-ketal") monomer and polymer technology, thereby providing the basis for subsequent formation of Segetis as dedicated to levulinic acid platform technology company. Sergey is the inventor of the concept and the core technology of Segetis. In January of 2007, Sergey and Olga have secured a $15MM Series A financing from Khosla Ventures for Segetis. Sergey had served as the first Segetis' President (2006-2008) and Chief Scientific Officer (2006-2009). In 2009 Sergey has been awarded the Governor's Certificate of Recognition, signed by Gov. Tim Pawlenty, for impact on the economy and welfare of the State of Minnesota and dedication to innovation.

Sergey has over 30 years of experience in biotechnology and chemistry. He has held research positions with the Institute of Biochemistry and Physiology of Microorganisms (USSR Academy of Sciences), Penn State, the U.S. Environmental Protection Agency, and the University of Minnesota. His research primarily focused on biocatalysis and chemistry of microbial metabolism for organic compounds of environmental or synthetic significance. Sergey was a Principal Investigator and co-PI in several competitively funded research programs. From 1997 to 2001 he worked for Maxygen, a Silicon Valley company pioneering molecular breeding technologies, where he made significant contributions to intellectual property and R&D programs in directed evolution and biocatalysis/chemicals. Sergey has 25 peer-reviewed publications, over 30 issued U.S. patents and numerous issued patents and pending patent applications worldwide in the fields of green chemistry, biotechnology, molecular evolution technologies and bio-based plastics and biodegradable polymers. Sergey received his M.S. in biology and chemistry from the Gorky State University USSR (Nizhny Novgorod, Russia). Sergey received his Ph.D. in biochemistry in 1990 from the Institute of Biochemistry and Physiology of Microorganisms, USSR Academy of Sciences, Moscow Region.


Olga Selifonova is Chief Executive Officer, Founder of Reluceo Holdings LLC since 2013. Prior to current position, Olga served as CEO of Reluceo Inc. and XLTerra, Inc. (2009-2013), Minnesota-based VC-backed green chemistry companies dedicated to development of renewable and degradable polymers such as non-acrylic superabsorbents (hydrogels) and high performance plastics from non-food biomass sources. Prior to Reluceo and XLTerra, Olga and Sergey co-founded Segetis, Inc., a Minnesota-based VC-backed green chemistry company developing levulinic acid and levulinic ketal-based products, and served as Segetis' vice president of corporate development (2007-2009).

With more than 30 years of diverse biotechnology experience Olga has held research positions at the M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, USSR Academy of Sciences, at Penn State University, the U.S. Environmental Protection Agency and the University of Minnesota. In 1997-2000 she worked at Genencor International in Palo Alto, CA, where she contributed to molecular evolution efforts and to the collaborative 1,3-propanediol project between DuPont and Genencor. The following 6 years Olga worked at Cargill's Biotechnology Development Center (BioTDC) in the area of metabolic engineering. Olga has first-hand experience with the development of bio-based industrial chemicals such as 1,3-propanediol, 3-hydroxypropionic and lactic acids. Olga has 12 peer-reviewed publications, 24 issued U.S. patents and a number of issued patents and pending patent applications worldwide in the fields of biotechnology, molecular evolution technologies and metabolic engineering for renewable chemical production. Olga received her M.S. degree in biology and chemistry from the Gorky State University, USSR. She completed her Ph.D requirements at the M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, USSR Academy of Sciences. Olga received an M.B.A. from Cardinal Stritch University.